• HPR109 Evaluation of Evidence Informing Medicare’s Coverage With Evidence Development Decision Updates

    Jun 1, 2024, 00:00

  • EPH4 Assessing the Association Between Body Mass Index, Cholesterol, and Cancer Among United States Adults in the Medical Expenditure Panel Survey Using a Cross-Sectional Design

    Jun 1, 2024, 00:00

  • EE238 The Budget Impact of Establishing a County-Level Cancer Prevention and Care Center in China

    Jun 1, 2024, 00:00

  • MSR23 Optimizing Regression Models for Patient-Level Utility Scores: A Case Study on Addressing Ceiling Effects in EQ-5D Data from the MYR301 Clinical Trial

    Jun 1, 2024, 00:00

  • EE252 Economic Impact of Relapses in Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD): A Systematic Literature Review

    Jun 1, 2024, 00:00

  • EE362 Analysis of the Cost of Pharmacological Care for Patients With Type 2 Diabetes Mellitus on the Colombian Atlantic Coast: 2019-2022 Risk Cohort Analysis

    Jun 1, 2024, 00:00

  • HTA1 Stakeholders Perspectives About Patient Participation in HTA in Latin America: Best Practices, Main Gaps, and Recommendations

    Jun 1, 2024, 00:00

  • P34 National Costs of Prescription Drug Market Exclusivity Extensions

    Jun 1, 2024, 00:00

  • RWD87 Real-World Treatment Patterns, Healthcare Costs, and Healthcare Resource Utilization in Patients in the US With Metastatic Non-Small Cell Lung Cancer Receiving Systemic Anticancer Therapy

    Jun 1, 2024, 00:00

  • HPR87 Assessing the Implementability of Regulatory Agencies’ Guidance on Diversity in Clinical Trials

    Jun 1, 2024, 00:00

  • EE416 Cost-Effectiveness of Sulbactam-Durlobactam Compared to Colistin in Treating Carbapenem-Resistant Acinetobacter Baumannii Infections in Critical Care Setting in the United States: A Decision Analysis

    Jun 1, 2024, 00:00

  • PCR170 Mental Health Status, Symptoms and Sleep Quality of Patients Hospitalized for Infection with COVID-19

    Jun 1, 2024, 00:00

  • Real-World Data Information Systems

    Jun 1, 2024, 00:00

  • PCR40 Evaluating the Evolution of Patient-Reported Outcome Measures (PROMs) in Health Technology Assessments: A Focus on Neurological Diseases in NICE Technology Appraisals

    Jun 1, 2024, 00:00

  • HSD119 Unveiling Priority Challenges in the Healthcare System for Ovarian Cancer: Advancement and Plausible Solutions

    Jun 1, 2024, 00:00

  • RWD179 Resource Utilization and Direct Costs of Diabetes in Relation to Heart Failure Status in Private Payer Perspective in Brazil

    Jun 1, 2024, 00:00

  • EE437 Evaluating Various Predictors Suspected of Influencing Biosimilar Market Share in the U.S.

    Jun 1, 2024, 00:00

  • RWD82 Treatment Patterns of Ulcerative Colitis and Crohn's Disease Patients in Taiwan: A National Health Insurance Research Database (NHIRD) Study

    Jun 1, 2024, 00:00

  • PCR231 Changes in Health-Related Quality of Life in Vivax Malaria Patients: Measurement and Valuation in Indonesia and Cambodia

    Jun 1, 2024, 00:00

  • Disclaimer

    Jun 1, 2024, 00:00

  • EPH130 Mortality Related with Respiratory Syncytial Virus (RSV) Specific and Unspecified Acute Bronchiolitis in Under 2 Years in Colombia, 2012-2021

    Jun 1, 2024, 00:00

  • CO110 Physical Examination of the Functional Status of the Hip and Spine in Junior Swimmers and Synchronised Swimmers

    Jun 1, 2024, 00:00

  • HTA53 Advances in Science and Challenges at HTA: The Case of CRISPR Technologies

    Jun 1, 2024, 00:00

  • EPH175 Assessment of Streptococcus Pneumoniae as Cause of Acute Otitis Media in Young Children in Colombia: A Prospective Study

    Jun 1, 2024, 00:00

  • MT47 Navigating the Roadblocks: Identifying the Complexities and Challenges of Artificial Pancreas in Management of Type 1 Diabetes Mellitus

    Jun 1, 2024, 00:00

  • EE497 The Cost-Effectiveness of Semaglutide 2.4MG in Patients With Overweight/Obesity and Cardiovascular Disease From the Select Trial

    Jun 1, 2024, 00:00

  • RWD113 Comparative Analysis of Vaping Use Disorder (VUD) and CDC Proxy Codes: A Demographic Perspective

    Jun 1, 2024, 00:00

  • CO33 Risk Factors for Increased Initial Hospital Length of Stay and 30-Day Readmissions in Patients with Relapsed/Refractory Large B-Cell Lymphoma Treated with Chimeric Antigen Receptor T-Cell Therapy at an Academic Cancer Center

    Jun 1, 2024, 00:00

  • RWD44 Key Components of a Strong Real World Data Quality and Relevance Package for Regulatory or Health Technology Assessment Submission

    Jun 1, 2024, 00:00

  • EPH131 Adolescent Pregnancy Before and During the SARS Cov-2 Pandemic in Cartagena De Indias, Colombia 2015 - 2021

    Jun 1, 2024, 00:00

  • HPR93 Price Evolution of Selected Cancer Immunotherapies in the US and Key European Markets

    Jun 1, 2024, 00:00

  • MT17 Patient Characteristics Associated with Intentions to Use a Blood Pressure Telemonitoring Device Among Adults with Hypertension in the United States

    Jun 1, 2024, 00:00

  • PCR99 Mixed Methods Research to Understand Disease Burden and Unmet Need in HDFN and FNAIT

    Jun 1, 2024, 00:00

  • Real-World Data Information Systems

    Jun 1, 2024, 00:00

  • HTA16 A Preliminary Assessment of ICER's New HTA Methods That Support Health Equity

    Jun 1, 2024, 00:00

  • EE280 Price Trends and Analysis of Targeted Immunomodulatory (TIM) Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Therapy

    Jun 1, 2024, 00:00

  • RWD6 Effect of Selumetinib Treatment on Pain Medication Utilization in Pediatric Patients: A US Claims Database Analysis

    Jun 1, 2024, 00:00

  • EE344 Expected Economic Savings Associated With Surgical Aortic Valve Replacement Using a Novel Tissue Bioprosthesis: An Update Based on the 7-Year Commence Trial Results

    Jun 1, 2024, 00:00

  • HPR20 Comparison of Biosimilar Reimbursement Policies in the US and Select European Markets

    Jun 1, 2024, 00:00

  • EPH234 Real-World Clinical Characteristics and Disease Management of Immunoglobulin a Nephropathy Patients Across the United States

    Jun 1, 2024, 00:00

  • MSR59 Advancing Systematic Literature Reviews: The Integration of AI-Powered NLP Models in Data Collection Processes

    Jun 1, 2024, 00:00

  • EPH157 Does COVID-19 Related Lockdown Restrictions Impact People With Musculoskeletal Disorders? A Systematic Review

    Jun 1, 2024, 00:00

  • EE476 Cost of COVID-19 Vaccine Delivery Integration into Routine Immunization and Service Delivery in South Africa

    Jun 1, 2024, 00:00

  • PCR242 Electronic Collection of Patient-Reported Outcome Measures in Dermatology Trials

    Jun 1, 2024, 00:00

  • P3 Longitudinal Analyses of Healthcare Resource Utilization and Costs Among Patients with Obstructive Hypertrophic Cardiomyopathy

    Jun 1, 2024, 00:00

  • EPH225 Characteristics of Patients with Transthyretin Amyloidosis and Methodological Approaches for Establishing Clinical Subtype in the Netherlands

    Jun 1, 2024, 00:00

  • PCR21 The Impact of Fathers' Supportive Role, Mood State Changes on Long-Term Breastfeeding in the Postpartum Period

    Jun 1, 2024, 00:00

  • PCR115 Health States Utilities for Allergic Rhinitis - an AI-Supported Systematic Review

    Jun 1, 2024, 00:00

  • HSD91 ‘It Is Not in Stock’: Identifying Determinants of Patient Deception in Community Pharmacies

    Jun 1, 2024, 00:00

  • MSR87 A Method to Estimate Effect of Treatment Switching By Assigning Pseudo-Switch Date Among Continuers

    Jun 1, 2024, 00:00

  • HPR99 Medicare Drug Price Negotiation: The Complexities of Selecting Therapeutic Alternatives for Estimating Comparative Effectiveness

    Jun 1, 2024, 00:00

  • MSR12 Use of Single Arm Studies/Disconnected Observational Studies in Comparative Effectiveness of Treatments for Fabry Disease: A Network Meta-Analysis Using a 3-Level Hierarchical Model

    Jun 1, 2024, 00:00

  • RWD165 Burden of Illness of Intrauterine Adhesions Following Intrauterine Procedures: A Retrospective Analysis of Real-World Data

    Jun 1, 2024, 00:00

  • CO122 Real-World Data on Inequity in Clinical Outcomes Among Adult Patients Diagnosed with Hypertrophic Cardiomyopathy

    Jun 1, 2024, 00:00

  • CO20 Treatment Regimens and Persistence in Colombian Patients Diagnosed With Rheumatologic Diseases After Failure of Conventional Disease-Modifying Antirheumatic Drugs

    Jun 1, 2024, 00:00

  • HSD23 Preferences and Attitudes of Healthcare Providers (HCPs) and Adult Healthcare Consumers (HCCs) Towards Pneumococcal Conjugate Vaccines (PCVs) in the United States (US)

    Jun 1, 2024, 00:00

  • EE250 Work Productivity Loss Among Adults Aged 18–64 Years With Osteoarthritis in the United States: 2016-2020

    Jun 1, 2024, 00:00

  • OP16 Analysis of Decision Factors and Recommendations for Incorporating Health Technologies in 6 HTA Agencies

    Jun 1, 2024, 00:00

  • EPH101 Estimating Total Number of Influenza Cases From Reported Hospitalizations: A Multi-Country Comparison of the Multiplier Method

    Jun 1, 2024, 00:00

  • CO189 Preliminary Outcomes of a Hearing Loss Screening Program of 5,360 Older Adults at the Medical University of South Carolina

    Jun 1, 2024, 00:00

  • HPR54 The European Health Data Space (EHDS): Probable Impact, Possible Challenges and Proposed Solutions to Using Electronic Health Records (EHRS) for Research and Policy Shaping in the Region

    Jun 1, 2024, 00:00

  • RWD66 Lung Cancer Chemotherapy-Associated Clostridium Difficile Infection Among Elderly Patients in the United States

    Jun 1, 2024, 00:00

  • PCR144 Generating Uptake Probabilities from Discrete-Choice Experiment-Derived Preferences for Application in Patient-Centered Value Assessment

    Jun 1, 2024, 00:00

  • EE401 Unlocking the Economic Potential of Digital Health Interventions in Cardiovascular and Metabolic Diseases

    Jun 1, 2024, 00:00

  • PCR147 Breaking a Vicious Cycle: Including the Patient Perspective for Meaningful Psoriasis Severity Evaluation Towards Broader Recognition of Burden and Unmet Needs

    Jun 1, 2024, 00:00

  • EPH148 Bridging the Gap: Understanding Prostate Cancer Patient Characteristics in Clinical Trials

    Jun 1, 2024, 00:00

  • EPH54 Enhancing BMI Data Accuracy: A Comparison of Claims and Electronic Health Records (EHR) Database

    Jun 1, 2024, 00:00

  • EE236 Healthcare Resource Utilization (HCRU) and Direct Medical Costs Following Acute SARS-Cov-2 Infection: Findings From a Literature Review

    Jun 1, 2024, 00:00

  • PCR98 Suboptimal Dosing and Discontinuation of Antifibrotic Agents in Patients with Idiopathic Pulmonary Fibrosis (IPF)

    Jun 1, 2024, 00:00

  • PCR19 Content-Related Validity of the Rand-36 Composite Scores with Other Patient-Reported Outcome Scales Among National Health and Wellness Survey Respondents in the United States, Japan, and 5 European Countries

    Jun 1, 2024, 00:00

  • PT19 Developing a Bespoke Neural Network Model for Diagnosing Alzheimer's Dementia: A Fit-for-Purpose Machine Learning Study

    Jun 1, 2024, 00:00

  • CO5 Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Cancer: A Target Trial Emulation From SEER-Medicare Database

    Jun 1, 2024, 00:00

  • EE154 The Economic Burden of HER2+ Breast Cancer and the Epidemiological Economic Impact of Targeted Therapies in the Dominican Republic

    Jun 1, 2024, 00:00

  • RWD167 Clinical Utilization of Sodium-Glucose Cotransporter 2 Inhibitors in Systolic and Diastolic Heart Failure at a Large Academic Hospital

    Jun 1, 2024, 00:00

  • MT40 Budget Impact of Implementing an Advanced Interventional Suite Platform for Interventional Procedures

    Jun 1, 2024, 00:00

  • MSR51 Evaluation of Machine Learning Approaches in Predicting the Initial Treatment Strategy in Patients with Multiple Sclerosis

    Jun 1, 2024, 00:00

  • CO174 Baseline Characteristics of Patients with Asthma and Prior Oral Systemic Corticosteroid Use Initiating Dupilumab in a Real-World Registry (RAPID)

    Jun 1, 2024, 00:00

  • RWD189 Exploration of Reason Codes in Real World Cardiovascular System Short-Term Disability Claims in the United States

    Jun 1, 2024, 00:00

  • EE326 Health Care Resource Utilization and Costs Among Patients with Paroxysmal Nocturnal Hemoglobinuria Initiating Eculizumab and Ravulizumab: A U.S. Claims Analysis

    Jun 1, 2024, 00:00

  • RWD141 Assessing the Potential Value of the Flatiron Health Commercial Mortality Data Combined with Publicly Available Death Data for Non-Oncology Research

    Jun 1, 2024, 00:00

  • EPH33 Trend of Mortality By Asthma in Colombia, 1998 - 2021

    Jun 1, 2024, 00:00

  • CO140 Heterogeneous Treatment Effects of an Intensive Lifestyle Intervention: Evidence From the Look Ahead Study

    Jun 1, 2024, 00:00

  • HSD47 Treatment Response, Healthcare Resource Use, and Economic Outcomes Associated With Tumor Necrosis Factor Inhibitor Cycling Versus Switching to an Advanced Therapy With Different Mechanism of Action in Rheumatoid Arthritis

    Jun 1, 2024, 00:00

  • Author Reply

    Jun 1, 2024, 00:00

  • EE466 Implementing the Generalized Risk-Adjusted Cost-Effectiveness (GRACE) Model for Sickle-Cell Disease: A Case Study

    Jun 1, 2024, 00:00

  • HSD86 Health Care Utilization before and during the COVID-19 Pandemic in Patients with Epithelial Ovarian Cancer

    Jun 1, 2024, 00:00

  • RWD147 Quantifying the Effectiveness of a RWD Quality Framework: A Case Study Using Paroxysmal Nocturnal Hemoglobinuria (PNH)

    Jun 1, 2024, 00:00

  • Assessing the Performance of Alternative Methods for Estimating Long-Term Survival Benefit of Immuno-oncology Therapies

    Jun 1, 2024, 00:00

  • EE427 The Reduction in Medical and Care Costs for Diseases Associated with Being Bedridden in Rural Residents in Japan

    Jun 1, 2024, 00:00

  • PCR164 Exploring Symptom Burden, Treatment Bother, Physical Function, and Quality of Life By Frailty Status in Patients with Colorectal Cancer (CRC)

    Jun 1, 2024, 00:00

  • EE335 Burden of Disease in Patients Who Are Eligible for Bcma-Targeted Immunotherapy for Multiple Myeloma: A Retrospective Claims Database Analysis

    Jun 1, 2024, 00:00

  • RWD12 Potentially Modifiable Risk Factors for Alzheimer Disease in Colombia: A Real-World Data Analysis

    Jun 1, 2024, 00:00

  • EE488 Cost-Effectiveness Analysis of Faricimab and Others Treatment Schemes for Diabetic Macular Edema and Age-Related Macular Degeneration

    Jun 1, 2024, 00:00

  • EE94 End-of-Life Costs Among Older Adults Living with HIV

    Jun 1, 2024, 00:00

  • HPR61 Impact of Changes in US Medicaid Reimbursement for Long-Acting Reversible Contraceptives in the Immediate Postpartum Period

    Jun 1, 2024, 00:00

  • MT29 Budget-Impact of Implementing an Outpatient Heart Failure Management System Following Diagnosis of Heart Failure

    Jun 1, 2024, 00:00

  • EPH89 Telehealth Utilization Among Children with Autism Spectrum Disorder in Employer-Sponsored Plans, 2019–2022

    Jun 1, 2024, 00:00

  • EE491 Modeling Costs of Variations in Healthcare Utilization Following the COVID-19 Pandemic: Exploring How Model Choices and Fit Impact Interpretation

    Jun 1, 2024, 00:00

  • RWD191 Real-World Ovarian Cancer Mortality Outcomes in a Brazilian Reference Women Healthcare Public Hospital

    Jun 1, 2024, 00:00

  • RWD124 Validation of Treatment Patterns in Adults With Chronic Inflammatory Demyelinating Polyneuropathy in the United States Using Administrative Claims Datasets

    Jun 1, 2024, 00:00

  • HPR117 Emergency Room Utilization Among Multiple Sclerosis Patients Treated with Disease-Modifying Therapy in a Real-World Hybrid Claims Database

    Jun 1, 2024, 00:00

  • CO126 Competing Risks of Death in Older Adults With Advanced Non-Small Cell Lung Cancer Receiving Programmed Cell Death Protein 1 (PD-1) Inhibitors

    Jun 1, 2024, 00:00

  • HSD115 Rates of Follow-up Colonoscopy After Positive Stool-Based Screening Test for Colorectal Cancer

    Jun 1, 2024, 00:00

  • PCR191 Patient-Centric Assessment of Treatment Experience in Breast Cancer: Development and Validation of a Patient Questionnaire

    Jun 1, 2024, 00:00

  • HSD16 Understanding Causes and Consequences in the Operating Room Associated with Distractions, Interruptions, and Disruptions: A Focused Literature Review

    Jun 1, 2024, 00:00

  • PCR131 Treatment Continuity, Adverse Events and Psychiatric Hospitalization for Incident Users of Second-Generation Antipsychotics Long-Acting Injections in Schizophrenia: One-Year Follow-up Study

    Jun 1, 2024, 00:00

  • HPR41 One Step Away From the Abyss? Analysis of the Supplementary Health System in Brazil

    Jun 1, 2024, 00:00

  • PCR23 The Effect of Obstetric Interventions on Breastfeeding: A Cross-Sectional Study

    Jun 1, 2024, 00:00

  • EE151 Clinical and Economic Benefits of Adjuvanted and High-Dose Influenza Vaccines in the Elderly in Argentina

    Jun 1, 2024, 00:00

  • RWD106 Psychological Burden in People Living with Myasthenia Gravis: Prevalence and Associated Risk Factors of Depression and Anxiety from the MGFA Global MG Patient Registry (MGFAPR) in the US (2017-2022)

    Jun 1, 2024, 00:00

  • EE452 Prevalence, Real-World Healthcare Resource Utilization, and Costs of Patients With Paroxysmal Nocturnal Hemoglobinuria in the US: A Retrospective Claims Database Analysis

    Jun 1, 2024, 00:00

  • EE450 JAV-RARAS: Valoriza a Jornada De Cuidado De Pacientes Com Mucopolissacaridose Tipo 2: Resultados Preliminares De Um Estudo Real No Sistema Único De Saúde (SUS)

    Jun 1, 2024, 00:00

  • HPR96 Racial Disparity and Awareness of Disease-Risk Genetic Testing: A Nationwide Sampling Survey Analysis

    Jun 1, 2024, 00:00

  • EE467 Estimation of Budget Impact With the Substitution of Biologic Reference Product for Biosimilars in Patients With Rheumatoid Arthritis From the Perspective of Medium Size Healthcare Insurance in Brazil

    Jun 1, 2024, 00:00

  • EE363 Economic Value of Early Genetic Testing in Inherited Retinal Dystrophy Diagnosis

    Jun 1, 2024, 00:00

  • EPH75 Herpes Zoster Risk Among Immunocompromised Adults in the United States: A Retrospective Cohort Analysis

    Jun 1, 2024, 00:00

  • Psychometric Properties of the EQ-5D-Y-5L for Children With Intellectual Disability

    Jun 1, 2024, 00:00

  • EE395 Cost-Effectiveness Analysis of Nivolumab Plus Relatlimab (NIVO+RELA) Versus Current Standard of Care (SOC) for Patients with Unresectable or Metastatic Melanoma in Canada

    Jun 1, 2024, 00:00

  • MSR94 A Flexible, Likelihood-Based Method for Estimating Underlying Distributions, Mean and SD-Based on Reported Quantiles Such as Median and Inter-Quartile Range

    Jun 1, 2024, 00:00

  • CO57 Impact of Coexisting Mental Illnesses and Chronic Conditions on Healthcare Utilization and Cost at Blue Cross and Blue Shield of Louisiana

    Jun 1, 2024, 00:00

  • EPH7 Examination of Weight-Related Coding Practices in Administrative Claims: Implications for Future Analyses

    Jun 1, 2024, 00:00

  • EE100 Exploring Frameworks and Methodologies to Incorporate Equity in Health Economics Evaluation: A Scoping Review

    Jun 1, 2024, 00:00

  • RWD37 Demographic, Chronic Disease, and Health Care Utilization Characteristics of Patients Self-Reporting Economic Insecurity in a Large Midwest Health System

    Jun 1, 2024, 00:00

  • PCR90 Patient Voice and Patient Engagement in Value Assessment Frameworks and HTA Decision-Making for Gene Therapies

    Jun 1, 2024, 00:00

  • HPR82 Assessment of Supporting Evidence and Postmarketing Requirements for Therapeutic Indications With Real-Time Oncology Drug Review, 2018-2023

    Jun 1, 2024, 00:00

  • EPH56 Validation of an Algorithm to Identify HR+/HER2- Metastatic Breast Cancer in Claims Data

    Jun 1, 2024, 00:00

  • EPH35 Self-Reported Hypertension and the Likelihood of Aspirin Use and Associated Adverse Effects Among Adults Aged 18 Years and Older

    Jun 1, 2024, 00:00

  • Novel Outcomes Research Data Methods

    Jun 1, 2024, 00:00

  • EPH40 Changing Role of Comorbidities in Risk of Mortality Among Elderly Patients Diagnosed with COVID-19 in the United States: Examining Pre- and Post-Vaccine Clinical Risk Factors

    Jun 1, 2024, 00:00

  • HPR19 Determining the Impact of Social Determinants of Health in the Prevalence of Diabetes in Mid-Atlantic Area

    Jun 1, 2024, 00:00

  • HPR130 Analysis of Forty-One Years of U.S. Food and Drug Administration Approvals, Regulatory Pathways, and Review Time of New Drugs and Biologics: A Retrospective Cohort Study

    Jun 1, 2024, 00:00

  • EE124 Real-World Mental Health Burden in Patients With Chronic Lymphocytic Leukemia

    Jun 1, 2024, 00:00

  • MSR33 Health State Transition Probabilities for Duchenne Muscular Dystrophy: Estimation from Published Data

    Jun 1, 2024, 00:00

  • RWD93 Obesity and Type 2 Diabetes: Analyzing Treatment Patterns and Socio-Economic Factors in Real-World Evidence

    Jun 1, 2024, 00:00

  • HPR69 State-Level Trends in Access to Medicaid Family Planning Services, 2008 – 2023

    Jun 1, 2024, 00:00

  • MT14 Assessing the Association Between Cardiovascular Acoustic Biomarkers and Heart Failure: A Systematic Literature Review

    Jun 1, 2024, 00:00

  • HPR5 National US Health Equity Survey Demonstrates Some Progress on Organizational Health Equity Goals, Emerging Priorities on Activation, Analytics, and Capacity Building

    Jun 1, 2024, 00:00

  • CO28 Assessing Disparities in Cardiovascular Outcomes across Payers in Patients Diagnosed with Hypertrophic Cardiomyopathy

    Jun 1, 2024, 00:00

  • PCR146 Real-World Multiple Myeloma Patient Experience By Frailty Status: Symptom Burden, Physical Function, Quality of Life, and Treatment Bother Captured from Electronic Patient-Reported Outcomes (ePROs)

    Jun 1, 2024, 00:00

  • RWD73 Repurposing Statins to Reduce the Risk of Alzheimer's Disease and Related Dementias: A Machine Learning Approach for Causal Estimates

    Jun 1, 2024, 00:00

  • EE50 Estimating the Clinical and Economic Outcomes of Universal Varicella and Herpes Zoster Vaccination in Belgium Using a Dynamic Transmission Model With Dynamic Population

    Jun 1, 2024, 00:00

  • PCR219 Disparities in Physical Function in Upper Limb Amputation: Influence of Race and Veteran Status

    Jun 1, 2024, 00:00

  • HSD71 Implementing Patient-Reported Outcomes in Clinical Practi The PROTEUS-Practice Framework Guide

    Jun 1, 2024, 00:00

  • SA71 Evaluation of Disease Burden (COMORBIDITIES, LENGTH OF HOSPITALIZATION AND HEALTHCARE RESOURCE UTILIZATION) from Respiratory Syncytial Virus (RSV) Illness in United Arab Emirates: A Retrospective Cohort Claims Database Study

    Jun 1, 2024, 00:00

  • P58 Clinical Impact of Replacing 13-Valent With a 15-Valent Pneumococcal Conjugate Vaccine in Costa Rican National Immunization Program

    Jun 1, 2024, 00:00

  • HPR97 Strategic Implications for Biopharmaceuticals: Navigating the Medicare Price Negotiation Provisions of the Inflation Reduction Act

    Jun 1, 2024, 00:00

  • HPR148 Identifying and Addressing Social Determinants of Health: A Health System Specialty Pharmacy Approach

    Jun 1, 2024, 00:00

  • PCR33 Study of the Effects of a 12 Week Functional Exercise Programme in the Hungarian Adult Population

    Jun 1, 2024, 00:00

  • EE525 Comparative Analysis of Launch Prices for Orphan Drugs in the US and EU4

    Jun 1, 2024, 00:00

  • EE34 JAV-RARAS: Methodological Aspects of Adherence Analysis to Clinical Protocols and Therapeutic Guidelines in Brazil

    Jun 1, 2024, 00:00

  • HSD109 Association Between Routine Colorectal Cancer Screening and the Risk of Colorectal Cancer Diagnosed at Advanced Stage and Total Cost of Care Among US Adults

    Jun 1, 2024, 00:00

  • HPR142 Review of Gene Therapy Access Landscape

    Jun 1, 2024, 00:00

  • RWD43 The Use of Code Llama, a Large Language Model, as Programming Assistant in Real-World Research

    Jun 1, 2024, 00:00

  • PCR102 Psychometric Validation of the Low Luminance Questionnaire (LLQ) in X-Linked Retinitis Pigmentosa (XLRP)

    Jun 1, 2024, 00:00

  • EPH207 Assessing Secular Trends in Cancer Stage at Initial Diagnosis in the United States Community Oncology Setting from 2015 to 2023

    Jun 1, 2024, 00:00

  • EE371 Treatment Patterns, Healthcare Resource Use, and Costs Among US Patients With Epidermal Growth Factor Receptor Mutated (EGFRm) Metastatic Non-Small Cell Lung Cancer (mNSCLC) After Discontinuation of Osimertinib

    Jun 1, 2024, 00:00

  • HSD111 Socio-Economic and Foeto-Maternal Characteristics of Home Childbirth in 12 African Countries: A Multinational Survey Using the Most Recent Demographic and Health Survey (DHS) Data

    Jun 1, 2024, 00:00

  • EE63 Cost-Effectiveness and Budget Impact of Pembrolizumab Monotherapy As the First-Line Treatment for Metastatic Non-Small Cell Lung Cancer Patients with PD-L1 ≥ 50% in Thailand

    Jun 1, 2024, 00:00

  • EE110 Leading Predictors of Medicare Payments Vary Across Different Phases of Care Among Older Hodgkin's Lymphoma Survivors: Application of Interpretable Machine Learning Models

    Jun 1, 2024, 00:00

  • CO185 Efficacy and Safety of Traditional Chinese Medicine for Acute Ischemic Stroke: A Systematic Review and Network Meta-Analysis

    Jun 1, 2024, 00:00

  • EE240 Economic Impact of Direct Costs Associated with Stroke in Patients with Type 2 Diabetes from the Perspective of the Social Security and Private Healthcare Providers in Argentina

    Jun 1, 2024, 00:00

  • RWD46 Real-World Clinical Burden of Friedreich Ataxia in the United States

    Jun 1, 2024, 00:00

  • MSR4 Making the Case for Negative Control Outcome Studies in a Real-World Evidence (RWE) Setting

    Jun 1, 2024, 00:00

  • EE157 Assessing the Cost-Effectiveness of Sodium Phenylbutyrate/Taurursodiol and Oral Edaravone in the Treatment of Amyotrophic Lateral Sclerosis

    Jun 1, 2024, 00:00

  • MSR50 Machine Learning Models for Predicting Metabolic Dysfunction-Associated Steatohepatitis (MASH) in the General United States Population

    Jun 1, 2024, 00:00

  • HSD79 Evaluation of Real-World Treatment Patterns in Patients With Uncontrolled Gout in the USA

    Jun 1, 2024, 00:00

  • PCR256 Asthma Control Levels and Their Impact on Health Related Quality of Life (HRQoL) of Asthma Patients in Quetta, Pakistan

    Jun 1, 2024, 00:00

  • EE190 Budget Impact Analysis of Zanubrutinib + Obinutuzumab for the Treatment of Relapsed or Refractory Follicular Lymphoma in the United States

    Jun 1, 2024, 00:00

  • HPR124 Is Obesity a Disease or a Lifestyle Issue in Europe and the United States? Payer Perception

    Jun 1, 2024, 00:00

  • CO171 Comparative Effectiveness of KarXT and Selective Second-Generation Antipsychotics for the Treatment of Schizophrenia: A Systematic Literature Review and Network Meta-Analysis

    Jun 1, 2024, 00:00

  • PCR230 Remote Symptom Alerts and Patient-Reported Outcomes (PROs) in Real-World Breast Cancer Practi Innovative Data to Derive Symptom Burden and Quality of Life

    Jun 1, 2024, 00:00

  • HTA43 Alignment Between Health Technology Assessment (HTA) Requirements and Current Practices in Global Value Dossier (GVD) Development

    Jun 1, 2024, 00:00

  • EPH221 Stigma As a Barrier to Treatment: Evidence from the National Health and Wellness Survey

    Jun 1, 2024, 00:00

  • EE117 Insights Into Sickle Cell Disease Hospitalizations and Outcomes: A Tale of 2 HCUP Databases

    Jun 1, 2024, 00:00

  • PCR7 The Impact of Different Therapeutic Modalities (STANDARD TREATMENT, THROMBOLYSIS, THROMBECTOMY) on the Quality of Life of Stroke Patients

    Jun 1, 2024, 00:00

  • SA14 Validating Gestational Age ICD-10 Codes in Claims Data With Physician-Reported Gestational Age on Non-Invasive Prenatal Screening

    Jun 1, 2024, 00:00

  • Health Policy Regulatory

    Jun 1, 2024, 00:00

  • EPH115 Sex Differences on Limitations in Physical Functioning and Overall Quality of Life of People Living with Myasthenia Gravis from the MGFA Global MG Patient Registry (MGFAPR) in the US

    Jun 1, 2024, 00:00

  • PCR15 Criteria for the Value Assessment for Medication Adherence-Enhancing Interventions

    Jun 1, 2024, 00:00

  • HSD20 Real-World Prescribing of Lecanemab in the United States

    Jun 1, 2024, 00:00

  • EE322 Addressing Decision Uncertainty in a Cost-Effectiveness Model of Opioid Use Disorder Treatments: Estimating the Value of Information and the Sample Size to Provide It

    Jun 1, 2024, 00:00

  • EE121 Economic Consequences of Persistence and Adherence to Lifelong Therapy for Patients with Presymptomatic Spinal Muscular Atrophy (SMA)

    Jun 1, 2024, 00:00

  • EE4 Should NICE Consider Adoption of a Societal Perspective? Comparison of the ICER 2023 Value Assessment Framework with the NICE 2022 Methods Guide

    Jun 1, 2024, 00:00

  • HSD42 Performance Assessment of a Disease-Agnostic Treatment Sequencing Heuristic for Deriving Line of Therapy (LOT) in a Real-World, Rare, Multi-Tumor Cohort across Tumor Mutational Burden (TMB) Status

    Jun 1, 2024, 00:00

  • CO145 Incidence of Acute Exacerbations Among Patients With Fibrotic Interstitial Lung Disease in the United States

    Jun 1, 2024, 00:00

  • EE315 Cost-Effectiveness of Obicetrapib As Adjunctive Therapy Compared to Maximally Tolerated Statins for Lowering LDL-c

    Jun 1, 2024, 00:00

  • PCR59 Shaping the Value Equation in Digital Healthcare: A Case Study on Digital Neurorehabilitation

    Jun 1, 2024, 00:00

  • EPH60 Real-World Treatment Patterns in Adults with Pemphigus Vulgaris in the United States

    Jun 1, 2024, 00:00

  • CO182 Intelligence Quotient (IQ) Scores Among Early-Treated Phenylketonuria (PKU) Patients: Results from a Systematic Literature Review (SLR)

    Jun 1, 2024, 00:00

  • HPR27 Optimizing Drug Market Exclusivity in the US and EU Markets

    Jun 1, 2024, 00:00

  • HTA72 Molnupiravir for Treatment of Non-Hospitalized Adults With Laboratory-Confirmed, Mild/Moderately Severe COVID-19: A Systematic Evidence Review With Meta-Analysis and Trial Sequential Analysis

    Jun 1, 2024, 00:00

  • CO183 Real-World Clinical Outcomes and Genomic Profiles of Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) Harboring Both AR-LBD Missense Mutations and AR Copy Number Amplifications

    Jun 1, 2024, 00:00

  • EE24 Analysis of out-of Pocket Payment Associated to Female Infertility in Hungary between 2015-2022

    Jun 1, 2024, 00:00

  • HSD80 The Current Landscape of Anti-Obesity Medication Coverage Policies and Utilization Rates in the Unites States: A Targeted Literature Review

    Jun 1, 2024, 00:00

  • PCR17 Evaluation of Quality of Life and Its Predictors Among Breast Cancer Patients Accessing Care at a Tertiary Hospital in Nigeria

    Jun 1, 2024, 00:00

  • PCR246 Short-Term Quality of Life Assessment in Total Hip Arthroplasty Patients in Different Health Care Sectors

    Jun 1, 2024, 00:00

  • P43 Cost-Effectiveness of Talquetamab-tgvs Vs Idecabtagene Vicleucel for Triple-Class Exposed Relapsed or Refractory Multiple Myeloma

    Jun 1, 2024, 00:00

  • SA48 Methods to Account for the Impact of COVID-19 in Real-World Retrospective Studies of Economic Outcomes: A Targeted Literature Review

    Jun 1, 2024, 00:00

  • PCR75 Unlock the Power of Plant-Based Diets: Integration into Public Education

    Jun 1, 2024, 00:00

  • RWD72 Decoding Medication Adherence, Mode of Prescription Filling, and Health Care Resource Utilization in Alzheimer’s: A Twelve-Month Analysis

    Jun 1, 2024, 00:00

  • CO125 Disease Burden of Epithelial Ovarian Cancer in Chinese Patients Under Current Care: A Model Simulation Study

    Jun 1, 2024, 00:00

  • HSD89 The Impact of Social Economic Status on Biologic Treatment Disparity in Inflammatory Bowel Disease

    Jun 1, 2024, 00:00

  • P55 Treatment and Outcomes in Metastatic Colorectal Cancer: A Causal Study Design Framework

    Jun 1, 2024, 00:00

  • EE424 Societal Costs of Spinal Muscular Atrophy Type 1 for Patients Treated with Onasemnogene Abeparvovec or Nusinersen in the United Kingdom

    Jun 1, 2024, 00:00

  • PCR104 The Self-Management Activities, Health Literacy and Health-Related Quality of Life of Patients with Type 2 Diabetes: A Structural Equation Modelling in Vietnam

    Jun 1, 2024, 00:00

  • Student Research in Economic Evaluation

    Jun 1, 2024, 00:00

  • Costs and Productivity Benefits of the Department of Veterans Affairs Maintaining Internal Systems and Strengthening Integrated Outside Networks Act Scribes Trial

    Jun 1, 2024, 00:00

  • EPH159 Burden of COVID-19 and Its Associated Clinical Characteristics in Colombia: A Retrospective Database Analysis

    Jun 1, 2024, 00:00

  • EE139 Intensification with Insulin Glargine 300 U/Ml (Gla-300) or First- Generation Basal Insulins (BIs) in People with Type 2 Diabetes (T2D) on Once-Weekly Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs): Deliver New-G

    Jun 1, 2024, 00:00

  • PCR267 Real-World Impact of Treated Hereditary Angioedema Attacks on Patients’ Quality of Life

    Jun 1, 2024, 00:00

  • HTA40 Nirmatrelvir/Ritonavir for Non-Hospitalized Adults With Mild/Moderately Severe COVID-19: A Systematic Evidence Review of Randomized Controlled Trials and Real-World Studies With Meta-Analysis and Trial Sequential Analysis

    Jun 1, 2024, 00:00

  • EE382 Effect and Economic Outcomes of the Polypharmacy Management System Platform for Common Diseases in the Elderly in China

    Jun 1, 2024, 00:00

  • SA55 Efficacy and Tolerability of Contingency Management and Cognitive-Behavioral Therapy With Pharmacotherapy or Placebo in Managing Stimulant Use Disorder: A Systematic Review and Meta-Analysis

    Jun 1, 2024, 00:00

  • HPR60 Use of Brand-over-Generic Preferred Drugs in Medicaid Programs

    Jun 1, 2024, 00:00

  • MSR41 Unleashing the Power of Large Language Models: Using Zero-Shot Relevancy Classification on Social Media Posts for Enhanced Automated Understanding of Online Pet Owner Conversations About Canine Pruritus

    Jun 1, 2024, 00:00

  • MSR32 Instrumental Variables to Address Non-Compliance in Randomized Control Trials: A Scoping Review

    Jun 1, 2024, 00:00

  • PCR110 Valuation of Child Health: A United States Value Set for the EQ-5D-Y-3L

    Jun 1, 2024, 00:00

  • EPH145 Feasibility of a Network Meta-Analysis Assessing Relative Effectiveness and Safety of Remdesivir Versus Other Treatments for COVID-19 Inpatients

    Jun 1, 2024, 00:00

  • PCR20 Assessing Activity Limitations Caused by Rheumatoid Arthritis to Inform Appropriate Selection of Patient-Reported Outcomes Measures

    Jun 1, 2024, 00:00

  • EPH102 Application of a Quasi-Experimental Study Design to Pharmacoepidemiology: An Evaluation of Immune Checkpoint Inhibitor Therapy and Cholangitis Using Real-World Data As a Case Study

    Jun 1, 2024, 00:00

  • HPR128 Benchmarking Clinical Trial Diversity: Methods to Characterize Eligibility-Based Representativeness

    Jun 1, 2024, 00:00

  • MSR21 Development and Application of a Framework for Addressing New Challenges of Missing Data in Real-World Research

    Jun 1, 2024, 00:00

  • EE162 A Claims Analysis to Characterize the Economic Burden of Generalized Pustular Psoriasis Among Patients in the United States

    Jun 1, 2024, 00:00

  • EPH29 Prevention and Treatment in the Global Tuberculosis Epidemic: Approaches and Strategies in Current Clinical Trials

    Jun 1, 2024, 00:00

  • CO148 The Impact of Approved Anti-Obesity Medications on Osteoarthritis Risk in Patients With Obesity: A Retrospective Cohort Study

    Jun 1, 2024, 00:00

  • CO205 Impact of GLP-1A Treatment on Eating Disorder Inciden A Comparative, Real World Data Study in Patients With and Without Pre-Existing Mental Health Conditions

    Jun 1, 2024, 00:00

  • PCR72 Adherence of Treatment in Psoriasis- A Systematic Literature Review

    Jun 1, 2024, 00:00

  • MSR44 How Accurate Are Large Language Models for Abstract Screening in Systematic Literature Reviews?

    Jun 1, 2024, 00:00

  • PCR178 Use of Patient Reported Outcomes in Registered Drug Studies for Long COVID

    Jun 1, 2024, 00:00

  • RWD104 Disease and Treatment Characteristics of Hodgkin's Lymphoma from Social Media Data: Application of Name Entity Recognition Natural Language Processing

    Jun 1, 2024, 00:00

  • RWD79 Evaluating the Impact of Anemia and Blood Transfusions on Patient Treatment Selection and Survival Rates for Patient With Myelofibrosis (MF) Using Real-World Data

    Jun 1, 2024, 00:00

  • EE257 Management of Psoriasis and Atopic Dermatitis Costs in the Poor Insured Population of the Colombian Atlantic Coast

    Jun 1, 2024, 00:00

  • HPR36 Barriers to Getting New Cancer Medicines to Patients in Kazakhstan

    Jun 1, 2024, 00:00

  • HSD87 Determinants of Innovative Drugs' Adoption: Evidence from Lithuania

    Jun 1, 2024, 00:00

  • MSR71 Development of an Open-Source Web Application for Probabilistic Value-Based Contracting Performance Estimation

    Jun 1, 2024, 00:00

  • CO52 Treatment History, Healthcare Resource Use, and Costs Among Patients With Pulmonary Arterial Hypertension (PAH) Initiating Treatment With Macitentan: A Retrospective Claims Analysis

    Jun 1, 2024, 00:00

  • EE403 Budget Impact of Selinexor Combination Regimens in Previously Treated Multiple Myeloma

    Jun 1, 2024, 00:00

  • EPH118 Reduction of Adolescent Pregnancy and the Increase in Intrauterine Device Insertion: Data from a Private Health Insurance Company in Brazil

    Jun 1, 2024, 00:00

  • CO68 Performance Diagnostic Examination of Women's Handball Players

    Jun 1, 2024, 00:00

  • EE372 Cost-Effectiveness Analyses of Continuous Renal Replacement Therapy (CRRT) System in Health Care System in LMIC/LATAM/Brazil

    Jun 1, 2024, 00:00

  • MSR15 Revolutionizing Systematic Literature Reviews: Harnessing the Power of Large Language Model (GPT-4) for Enhanced Research Synthesis

    Jun 1, 2024, 00:00

  • EPH170 The Net Environmental Impact of Preventative Healthcare - Vaccination's Potential in the Fight Against Climate Change

    Jun 1, 2024, 00:00

  • MT28 Perspectives for Innovative Medtech Production in Ukraine: Challenges and Opportunities

    Jun 1, 2024, 00:00

  • EPH49 Prevalence and Incidence of ROS1 and NTRK Rearrangements in Real-World Patients With Advanced Non–Small Lung Cancer in the United States

    Jun 1, 2024, 00:00

  • RWD68 The TriNetX Linked EHR and Administrative Claims Network

    Jun 1, 2024, 00:00

  • HPR49 Real World Evidence and Rare Disease Considerations Across Regulatory and Health Technology Assessment Frameworks in the US, UK, and Canada

    Jun 1, 2024, 00:00

  • EPH109 The Effect of Metformin Adherence on the Reduction of Fracture Risk Among Type 2 Diabetes Patients

    Jun 1, 2024, 00:00

  • PCR223 Considerations for the Development of Treatment Efficacy/Benefit Attributes and Levels in Patient Preference Studies

    Jun 1, 2024, 00:00

  • EPH204 Chronic Liver Disease Is Associated with Greater Risk of Hospital Readmission in Patients with Heart Failure: A Nationwide Database Study in the US

    Jun 1, 2024, 00:00

  • PCR172 Patient-Reported Outcomes in Non-Small Cell Lung Cancer: Psychometric Evaluation of the PROMIS PF-SF 8C and NSCLC-SAQ in Phase 3 Clinical Trials

    Jun 1, 2024, 00:00

  • HTA64 Characteristics of Cell and Gene Therapies Authorized By the Food and Drug Administration and the European Medicines Agency

    Jun 1, 2024, 00:00

  • PCR96 Exploring Patient Preferences through Cross-Sectional Discrete Choice Experiment: An Insight into Once-Daily Stroke Prevention Treatments in Atrial Fibrillation in Asia

    Jun 1, 2024, 00:00

  • CO54 Timely Rheumatoid Arthritis Control With Biologic or Targeted Synthetic DMARDs in Clinical Practi Separating Successes From Opportunities for Care Improvement

    Jun 1, 2024, 00:00

  • RWD60 Evaluating Trends in the Use of RWE in FDA New Drug Approvals

    Jun 1, 2024, 00:00

  • SA3 Quality of Systematic Literature Reviews of Health Economic Models

    Jun 1, 2024, 00:00

  • RWD21 Assessing Dementia: An Analysis of Cognitive Scores, Pharmacy Costs, and Medication Adherence Using Unstructured and Structured Data

    Jun 1, 2024, 00:00

  • EE474 Value Assessment Under Uncertainty: Measuring Insurance Value and Risk Aversion for a Novel Neurological Treatment Using a Stated Preference Survey

    Jun 1, 2024, 00:00

  • HTA50 A Review of Real-World Evidence in Non-Oncology Submissions Made to Four Health Technology Assessment (HTA) Agencies

    Jun 1, 2024, 00:00

  • RWD134 Learnings From Linking Closed Claims Patient Cohorts With Consumer SDOH Data

    Jun 1, 2024, 00:00

  • SA67 Demographic and Clinical Characteristics of Patients Who Delayed, Skipped, or Continued Care During the First Year of the COVID-19 Pandemic and the Study Design Implications

    Jun 1, 2024, 00:00

  • EPH190 Trends and Disparities in Perinatal Health Outcomes Among Women from Refugee Backgrounds in Victoria, Australia: A Population-Based Study

    Jun 1, 2024, 00:00

  • EE53 A Cost of Illness Analysis of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML) With FLT3 Mutations in Chile: A Public Payer Perspective

    Jun 1, 2024, 00:00

  • EE470 The Impact of a Cost Savings Cap on the Cost Effectiveness of Valoctocogene Roxaparvovec for the Treatment of Hemophilia A in the United States

    Jun 1, 2024, 00:00

  • SA74 Trends in Publication of Budget Impact and Cost Utility Analyses from 2000-2022 in the United States

    Jun 1, 2024, 00:00

  • P27 Uptake and Costs of Rituximab Biosimilars Among the Medicare and Medicaid Populations in 2019-2021 in the United States

    Jun 1, 2024, 00:00

  • EPH217 Annual Epidemiological and Health Insurance Disease Burden of Endometriosis in Hungary Based on Real-World Health Insurance Claims Data

    Jun 1, 2024, 00:00

  • EE25 Economic Benefit of Faricimab Compared to Aflibercept 8mg in Treating Patients with Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema in the United States

    Jun 1, 2024, 00:00

  • CO40 Zero Dollar Drug Co-Pay Program Increases Medication Adherence and Utilization Among Members With Diabetes in Louisiana

    Jun 1, 2024, 00:00

  • PCR175 Screening for Anxiety and Depressive Symptoms in Adolescents With Complex Health Conditions From a Longitudinal Registry Study in Los Angeles County: Comparative Performance of the EQ-5D-5L and PedsQL

    Jun 1, 2024, 00:00

  • MSR81 Quantitative Assessment of Effect Modifiers in NMA - Leveraging Subgroup Data

    Jun 1, 2024, 00:00

  • PCR44 Real-DMD: Baseline Findings From an Electronic Observer-Reported Outcome (OBSRO) Survey of Long-Term Real-World Experiences of Patients with Duchenne Muscular Dystrophy (DMD)

    Jun 1, 2024, 00:00

  • RWD135 Right-Sided vs Left-Sided Colorectal Cancer Hospitalization Outcomes in the US

    Jun 1, 2024, 00:00

  • PCR119 Treatment Persistence Among Treatment-Experienced People With HIV (PWH) Switching To Integrase Strand Transfer Inhibitor (INSTI)-Based HIV Antiretroviral Regimens

    Jun 1, 2024, 00:00

  • EPH191 Age-Related Trends of Blood Glucose, Hyperglycemia, and Type 2 Diabetes in Youth Prescribed Second-Generation Antipsychotic Medications

    Jun 1, 2024, 00:00

  • MT1 Health State Utility Value (HSUV) Elicitation in Medical Technology and Digital Health (DH): How Do They Compare to Pharmaceuticals? A Targeted Literature Review (TLR) of Interventions in Type 2 Diabetes Mellitus (T2DM)

    Jun 1, 2024, 00:00

  • Economic Evaluation

    Jun 1, 2024, 00:00

  • EE179 Cost Effectiveness of Mastectomies of BRCA1 and BRCA2 Positive Women over Olaparib

    Jun 1, 2024, 00:00

  • EE43 Understanding the Humanistic and Economic Burden Associated with Early-Stage HR+/HER2- Breast Cancer: A Systematic Literature Review

    Jun 1, 2024, 00:00

  • HSD53 Community Oncologists’ Perceptions of Molecular Profiling: Insights into Precision Oncology Integration

    Jun 1, 2024, 00:00

  • PCR82 Fostering Peer-Reviewed Publication of Patient Engagement Activities: Multistakeholder Perspectives on Priorities, Motivators and Challenges

    Jun 1, 2024, 00:00

  • EE39 Economic Evaluation of Botulinum Toxin Type A (XEOMEEN) in the Treatment of Pediatric Patients With Spasticity in the "IMSS” and “ISSSTE”

    Jun 1, 2024, 00:00

  • MSR39 Machine Learning Applications in Predicting the Onset of Psoriatic Arthritis: A Systematic Review

    Jun 1, 2024, 00:00

  • PCR216 Exploring Quality of Life in Spinal Muscular Atrophy Patients through Vignette-Based EQ-5D-5L Measurements

    Jun 1, 2024, 00:00

  • CO194 Evaluating the Clinical Phenotypes Associated with Progression to Chronic Kidney Disease Using an Unsupervised Machine Learning Approach

    Jun 1, 2024, 00:00

  • EPH169 Integrating Structured and Unstructured Data in Total Hip Arthroplasty Evaluation: A Comprehensive Analysis for Enhanced Device Safety

    Jun 1, 2024, 00:00

  • HPR13 A County-Level Deprivation Index for China in 2020 and Its Association With Life Expectancy and Infant Mortality

    Jun 1, 2024, 00:00

  • SA23 Selection of Characteristics for Matching Adjusted Indirect Comparison in a Functional Mitral Regurgitation Population

    Jun 1, 2024, 00:00

  • HPR48 Factors Associated With Drug Overdose Mortality Rate in California

    Jun 1, 2024, 00:00

  • CO67 Network Meta-Analysis to Compare the Efficacy Between Different Classes of PCSK9 Inhibitors, siRNA Vs. PCSK9 mAb, in Asian Patients With Hypercholesterolemia at Increased Cardiovascular Risk

    Jun 1, 2024, 00:00

  • EE149 Economic Burden of Treating Chronic Peripheral Neuropathic Pain in the United States: National Estimates From 2022 Data

    Jun 1, 2024, 00:00

  • HSD19 Provider Perceptions of Barriers to Biosimilar Utilization in Community Oncology Practices

    Jun 1, 2024, 00:00

  • EE413 Predictive and Interpretable Machine Learning of Economic Burden: The Role of Chronic Conditions Among Patients with Incident Primary Merkel Cell Carcinoma

    Jun 1, 2024, 00:00

  • EE493 Sociodemographic Factors of Asthma Prevalence and Costs for Children in the United States, 2016-2021

    Jun 1, 2024, 00:00

  • EE265 Treatment Patterns, Healthcare Resource Utilization and Costs, and Clinical Outcomes Among Elderly Patients With Advanced HER2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma

    Jun 1, 2024, 00:00

  • EE243 Targeted Literature Review of Cost-Effectiveness Analyses in Sickle Cell Disease: Identifying the Optimal Modeling Approach for Therapies Targeting Sickle Hemoglobin Polymerization

    Jun 1, 2024, 00:00

  • SA73 Factors Affecting the Development Process of Health Tourism in Colombia: A Systematic Literature Review

    Jun 1, 2024, 00:00

  • Economic Evaluation

    Jun 1, 2024, 00:00

  • RWD14 Healthcare Resource Utilization and Associated Costs in COPD Patients at High Risk of Exacerbation Despite Treatment With Dual or Triple Inhaled Therapy: Results From the Sirius Observational Study in the US

    Jun 1, 2024, 00:00

  • RWD24 Real-World Evidence of the Clinical and Sociodemographic Characteristics of Patients with Atopic Dermatitis in Colombia: The Update Results of RENDAC

    Jun 1, 2024, 00:00

  • CO135 Comparative Efficacy, Safety, and Tolerability of KarXT Versus Aripiprazole and Cariprazine for the Acute Treatment of Adults With Schizophrenia: A Network Meta-Analysis

    Jun 1, 2024, 00:00

  • RWD58 Ketamine-Associated Adverse Events: An Analysis of the FAERS Database From 2012 - 2021

    Jun 1, 2024, 00:00

  • PCR194 Examination of the Subjective Assessment of General Physical and Mental Health, Social Relationships, and Exercise Regularity Among Hungarian Football Players and Professionals during the Pandemic

    Jun 1, 2024, 00:00

  • MSR42 Advancing Meaningful Change: Generating between-Group and within-Person Thresholds for the Asthma Daytime and Nighttime Symptom Diaries

    Jun 1, 2024, 00:00

  • RWD50 Progression-Free Survival after First-Line Treatment in Endometrial Cancer Patients: A Real-World Perspective from Brazil and Argentina

    Jun 1, 2024, 00:00

  • HTA82 Adjusting Utilities Using Age and Time-to-Death Decrements in Cost-Effectiveness Analyses: A Case Study in Relapsed and/or Refractory Multiple Myeloma

    Jun 1, 2024, 00:00

  • EE456 The Cost of Reusable Cystoscopy: A Microcosting Evaluation at a U.S. Academic Medical Center

    Jun 1, 2024, 00:00

  • SA5 A Scoping Review of Barriers and Facilitators to Implementation of Intravenous Cardiovascular Treatments in Ambulatory Settings

    Jun 1, 2024, 00:00

  • EE199 Budget Impact Analysis of the Anti-Vegfs Injections for Treating Diabetic Macular Oedema: Assessing Their Affordability in the UK Healthcare System

    Jun 1, 2024, 00:00

  • RWD136 Regulatory Vs HTA Divergences- Can the Real-World Evidence (RWE) be the Connecting Bridge?

    Jun 1, 2024, 00:00

  • PCR83 Comparison of Functional Status of Knee Replacement Patients with Individual and Serial Prostheses

    Jun 1, 2024, 00:00

  • Clinical Outcomes

    Jun 1, 2024, 00:00

  • EE319 Cost-Effectiveness of Assigning Early Interventions to Infants at High Risk for Autism Spectrum Disorder Using MRI Screening

    Jun 1, 2024, 00:00

  • EE44 Outcomes and Cost-Effectiveness of Hospital Outpatient Versus Ambulatory Surgery Center Lumbar Decompression Surgery

    Jun 1, 2024, 00:00

  • HSD59 Social Determinants of Health and Medication Adherence Among Older Adults With Chronic Conditions: Cross-Sectional Analysis of National Health and Nutrition Examination Survey (NHANES) 2009-2018

    Jun 1, 2024, 00:00

  • RWD11 Clinical and Humanistic Burden Associated with Alzheimer's Disease in the United States: An Analysis of Patient Characteristics, Treatment Patterns, and Quality of Life Using a Physician Notes Real-World Database

    Jun 1, 2024, 00:00

  • HTA25 Benefit-Risk Assessment of Medical Products Using Bayesian Multi-Criteria Augmented Decision Analysis (MCADA)

    Jun 1, 2024, 00:00

  • RWD23 Development of an Optimal Corticosteroid Dosage Regimen for the Management of Acute Respiratory Distress Syndrome: A Sequential Explanatory Mixed Method Approach

    Jun 1, 2024, 00:00

  • EPH186 Real-World Biomarker Prevalence and Treatment Patterns Among Metastatic Colorectal Cancer Patients Who Underwent NGS Testing

    Jun 1, 2024, 00:00

  • EPH196 A Claims-Based Analysis of Weight Management in Pediatric Populations Covered By Commercial or Medicaid Insurance

    Jun 1, 2024, 00:00

  • EE420 Development and Validation of a Markov Model for the Evaluation of a One-Time Universal Screening for Hepatitis B in Adults

    Jun 1, 2024, 00:00

  • AI and Machine Learning to Address Equity and Fairness in Healthcare

    Jun 1, 2024, 00:00

  • EPH222 Trends of Mortality Related With Dengue in Colombia 2012-2021

    Jun 1, 2024, 00:00

  • RWD76 Prognosis of Myelodysplastic Syndrome Using De-Identified Market Clarity Database

    Jun 1, 2024, 00:00

  • CO89 Comparative Effectiveness and Safety of Abaloparatide and Teriparatide in the Treatment of Osteoporosis in Postmenopausal Women: A Systematic Review and Meta-Analysis

    Jun 1, 2024, 00:00

  • EE72 Economic Burden of Long-Term Care (LTC) in Patients with Advanced Huntington's Disease (HD) and the Impact on Caregivers in North America: A Systematic Literature Review (SLR)

    Jun 1, 2024, 00:00

  • EPH3 Potential Public Health Impact of Bivalent Respiratory Syncytial Virus Stabilized Prefusion F Subunit Vaccine (RSVpreF) Among Older Adults in Canada

    Jun 1, 2024, 00:00

  • EE294 Cost-Effectiveness Analysis of the Implementation of Single-Dose Vitamin D, Omega 3, or Co-Supplementation on Individuals with PCOS

    Jun 1, 2024, 00:00

  • PCR100 Health-Related Quality of Life of Adolescents with Asymptomatic Convergence Insufficiency in China

    Jun 1, 2024, 00:00

  • RWD70 Dental Complication Burden in Patients with Phosphorus Metabolism and Phosphatase Disorders: Insights from a 14-Year Nationwide Longitudinal Retrospective Study in South Korea

    Jun 1, 2024, 00:00

  • HTA8 Identification of Cost-Effectiveness Evidence in UK NICE Single Technology Assessment Company Submissions: Databases, Sources and Currency of Searching

    Jun 1, 2024, 00:00

  • PT11 Impact of the Inflation Reduction Act on Payer Utilization Management – Insights from a Quantitative Survey

    Jun 1, 2024, 00:00

  • HSD15 The Economic and Humanistic Burden of Glioma in the United States and Canada

    Jun 1, 2024, 00:00

  • P64 Which Healthcare-System Factors Influence Reimbursement Success Rates? A Multi-Country Analysis of Reimbursement Decisions in 2023

    Jun 1, 2024, 00:00

  • RWD102 Exploring the Potential of Real-World Data Sources in Oncology and Rare Diseases: A North American Perspective

    Jun 1, 2024, 00:00

  • PCR24 Exploring the Content and Psychometric Validity of Clinical Outcome Assessments in Pancreatic Ductal Adenocarcinoma Versus the Patient Reported Symptoms and Impacts

    Jun 1, 2024, 00:00

  • MSR28 Use of Large Language Model (LLM) for Full-Text Screening in Systematic Literature Reviews: A Comparative Analysis

    Jun 1, 2024, 00:00

  • HPR58 Mapping Medicaid: A Comparative Analysis of State-Level Racial and Ethnic Data Collection to Federal Guidelines

    Jun 1, 2024, 00:00

  • EE342 Development of a Markov Model for Assessing the Cost-Effectiveness of Chronic Weight Management Interventions

    Jun 1, 2024, 00:00

  • EPH106 Real-World Assessment of Cardiovascular Risk Factors Among Women with a Combined Hormonal Contraception Prescription in the United States: An Electronic Health Records Study

    Jun 1, 2024, 00:00

  • PCR187 Continuous Glucose Monitoring Adherence and Healthcare Costs in Adult Patients With Diabetes: Examining the Impact of Device Sourcing

    Jun 1, 2024, 00:00

  • CO202 Relationship between Loss of Ambulation (LoA) and Timing of Pulmonary Outcomes Among Boys with Duchenne Muscular Dystrophy (DMD)

    Jun 1, 2024, 00:00

  • EE57 Missed Opportunities? Gaps in Capturing the Full Value of Vaccination Across Health Economic Studies of COVID-19 Vaccination

    Jun 1, 2024, 00:00

  • HSD75 Factors Associated With the Use of Immune Checkpoint Inhibitors in Older Adults With Metastatic Non-Small Cell Lung Cancer and Pre-Existing Autoimmune Disease: A SEER-Medicare Study

    Jun 1, 2024, 00:00

  • EE454 Economic Burden of Mild and Moderate Asthma in Adult Patients From Public Health Institutions Perspective in Mexico

    Jun 1, 2024, 00:00

  • SA31 Fall-Related Risks with Pharmacological Interventions in Mild-to-Moderate Alzheimer’s Disease: A Bayesian Network Meta-Analysis

    Jun 1, 2024, 00:00

  • CO142 Predisposing, Enabling, and Need Factors Associated With Postpartum Depression Treatment Among Women Enrolled in Texas Medicaid

    Jun 1, 2024, 00:00

  • SA29 Motivations and Barriers for Psychiatric Practice Adoption of Esketamine Nasal Spray for Treatment-Resistant Depression in the United States

    Jun 1, 2024, 00:00

  • EPH209 Using Real-World General Practitioner Data To Study the Diagnosis and Management of Dementia: Rationale and Design

    Jun 1, 2024, 00:00

  • EE309 Cost-Effectiveness Analysis of Velmanase Alfa in Patients with Alpha Mannosidosis from a UK Health Service Perspective

    Jun 1, 2024, 00:00

  • HTA67 Assessing Relationships Between the Canadian Agency for Drugs and Technologies in Health (CADTH) Revised ICERs and Unmet Need, Clinical Benefit, Price Reductions, and Listing Negotiation Timelines

    Jun 1, 2024, 00:00

  • HPR133 Clinical Benefits of the Accelerated Approval Program in Oncology

    Jun 1, 2024, 00:00

  • EE35 Air Pollution-Related Health Disutility and Mitigation Policy Favorability Amongst California’s San Joaquin Valley Residents: A Health Economics Perspective on Equity

    Jun 1, 2024, 00:00

  • CO143 Clinical Outcomes of First-Line (1L) Treatments (Txs) in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (aNSCLC): A Systematic Literature Review (SLR)

    Jun 1, 2024, 00:00

  • HPR33 Short- and Long-Term Impacts of the National Essential Medicines Policy on Drug in Rural China

    Jun 1, 2024, 00:00

  • EE391 Cost-Effectiveness of Radar: An Innovative Model to Organize Diabetes Care in First Nations Communities in Canada

    Jun 1, 2024, 00:00

  • PCR243 Examining the Relevance of the SF-36v2 for Assessment in HDFN or FNAIT-Affected Pregnancies: Results of a Landscape Assessment and Clinician and Patient Interviews

    Jun 1, 2024, 00:00

  • RWD163 Medication Adherence and Persistence on Selumetinib Treatment in Pediatric Patients: A US Claims Database Analysis

    Jun 1, 2024, 00:00

  • MSR72 An Evaluation of the Rayyan Artificial Intelligence Tool for Systematic Literature Review Screening

    Jun 1, 2024, 00:00

  • HPR121 Impacts of National Drug Price Negotiation on Chronic Myeloid Leukemia Drugs Price, Volume and Spending in China

    Jun 1, 2024, 00:00

  • HSD54 Assessing the Impact of Telehealth Delivery on Adherence to Medications for Opioid Use Disorder

    Jun 1, 2024, 00:00

  • PCR46 A Qualitative Exploration of Patient and Healthcare Provider Perspectives on Oxybate Treatments for Narcolepsy

    Jun 1, 2024, 00:00

  • EE447 Evaluating the Impact of Disease Prevalence and Product Administration on Launch Pricing Trends for Non-Oncology Orphan Products

    Jun 1, 2024, 00:00

  • RWD57 Trends and Factors Affecting the Initiation of Denosumab and Zoledronic Acid Among Metastatic Lung, Breast, and Prostate Cancer Patients in the United States

    Jun 1, 2024, 00:00

  • HTA60 What Utilization Management Strategies Does ICER Recommend to US Payers and Policy-Makers to Manage Uncertainty with Gene Therapies?

    Jun 1, 2024, 00:00

  • HPR150 Beyond the Headline: Inflation-Adjusting ICER's Unsupported Price Increase Results

    Jun 1, 2024, 00:00

  • EE52 The Burden of Intravenous vs Subcutaneous Oncological Products Application in Honduras

    Jun 1, 2024, 00:00

  • HPR37 Racial Disparities in Homologous Recombination Repair (HRR) Biomarker Testing in the United States: A Real-World Database Analysis Among White and Non-White Patients with Metastatic Prostate Cancer

    Jun 1, 2024, 00:00

  • HPR70 Racial Disparity and Utilization of Disease-Risk Genetic Testing: A Nationwide Sampling Survey Analysis

    Jun 1, 2024, 00:00

  • PCR166 Real-World Discontinuation of High-Efficacy Disease Modifying Therapies for the Treatment of Multiple Sclerosis: A Targeted Literature Review

    Jun 1, 2024, 00:00

  • CO72 Investigating Regional Differences in Cardiovascular Outcomes Among Patients Diagnosed with Hypertrophic Cardiomyopathy

    Jun 1, 2024, 00:00

  • EE92 Trends in Incidence and Economic Burden of Pneumonia in the United States from 2016-2021

    Jun 1, 2024, 00:00

  • CO60 A Vocation for Life on Land, Sea and Air - Health Assessment of Ambulance Workers

    Jun 1, 2024, 00:00

  • MSR88 The Influence of Social Determinants of Health on Healthcare Access, Utilization, and Treatments in Atopic Dermatitis Patients Using All of Us and Machine Learning Methods

    Jun 1, 2024, 00:00

  • MSR93 Patient Cloning for Assessing Dynamic Treatment Protocols: A Novel Approach for Observational Data Analysis Using Real-World Data (RWD)

    Jun 1, 2024, 00:00

  • CO18 Impact of Empiric Treatment Failure on Healthcare Resource Utilization and Costs Among Females With Uncomplicated Urinary Tract Infections in a US-Based Integrated Health Delivery Network

    Jun 1, 2024, 00:00

  • HTA20 Population Adjusted-Indirect Comparisons in Health Technology Assessment: A Methodological Systematic Review

    Jun 1, 2024, 00:00

  • MT6 Clinical Significance of SP-D Biomarker in the Diagnosis of Connective Tissue Disease-Associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis

    Jun 1, 2024, 00:00

  • MSR16 Examining Fairness in Machine Learning Predictions of Healthcare Costs in Older Women With Osteoarthritis: XGBoost Regression

    Jun 1, 2024, 00:00

  • EE109 BoNT-As for Adult Upper Limb Spasticity: Cost of Treatment and Response to Therapy in Canadian Patients

    Jun 1, 2024, 00:00

  • CO178 Access to Preventive Care and Social Determinants of Child Obesity: A Retrospective Cohort Study Using the Pinc AI™ Healthcare Database (PHD)

    Jun 1, 2024, 00:00

  • PCR35 Impact of COVID-19 Vaccination with BNT162b2 on the Frequency of Acute Symptoms Among Symptomatic US Adults Testing Positive for SARS-CoV-2 at a National Retail Pharmacy

    Jun 1, 2024, 00:00

  • OP15 Correlation between Quality of Care and Financial Risk Indicators in Public Hospitals

    Jun 1, 2024, 00:00

  • Epidemiology Public Health

    Jun 1, 2024, 00:00

  • Epidemiology Public Health

    Jun 1, 2024, 00:00

  • RWD25 Trends and Utilization of Open, Laparoscopic, and Robotic-Assisted Appendectomy: A Retrospective Database Study

    Jun 1, 2024, 00:00

  • CO25 Examining the Effectiveness of Rotator Cuff Training on Shoulder Joint Stability, Mobility and Shooting Accuracy Among Basketball Players

    Jun 1, 2024, 00:00

  • RWD110 Group-Based Trajectory Modeling to Identify Longitudinal Patterns of Adherence to Oral Antidiabetic Medication in Older Adults on Concomitant Triple Therapy (Oral Antidiabetics, RAS Antagonists, Statins)

    Jun 1, 2024, 00:00

  • EE383 Cost-Utility Analysis of Adapted Problem Adaptation Therapy for Depression in Mild to Moderate Dementia Caused by Alzheimer's Disease: Pathfinder Randomized Controlled Trial

    Jun 1, 2024, 00:00

  • HSD22 Extending External Validity of Rcts and Meta-Analysis through Transportability Analysis and Integration of Mechanistic Research Evidence

    Jun 1, 2024, 00:00

  • CO1 The Rate of Ward to Intensive Care Transfer and Its Predictors Among Hospitalized COPD Patients: A Retrospective Study in a Local Tertiary Center in Saudi Arabia

    Jun 1, 2024, 00:00

  • HPR101 Impacts of the CDC’s 2016 Guideline for Prescribing Opioids for Chronic Pain on Opioid Prescribing and Pain Management Outcomes: A Systematic Review

    Jun 1, 2024, 00:00

  • PCR182 A Triangulation Approach to Develop a Conceptual Framework for the Patient-Reported Outcome Measures across the Life Cycle: A Case of Patients with X-Linked Hypophosphatemia

    Jun 1, 2024, 00:00

  • RWD178 Costs of Cancer Care Across the Disease Continuum: An Analysis From a Health Payer Perspective in Brazil

    Jun 1, 2024, 00:00

  • RWD56 Expert Consensus on Diagnosis, Risk Stratification, and Treatment of Smoldering Multiple Myeloma: Results From a Multinational Delphi Panel Study

    Jun 1, 2024, 00:00

  • PCR14 Development and Validation of Two New Patient-Reported Outcome Measures for Recurrent Urinary Tract Infection: The Recurrent UTI Symptom Scale (RUTISS) and the Recurrent UTI Impact Questionnaire (RUTIIQ)

    Jun 1, 2024, 00:00

  • MT38 Electromagnetic Navigation Bronchoscopy (ENB) Versus Shape-Sensing Robotic-Assisted Bronchoscopy (ssRAB) Lung Navigation Platforms: A Cost-Minimization Analysis

    Jun 1, 2024, 00:00

  • P48 Automating Economic Modelling: Potential of Generative AI for Updating Excel-Based Cost-Effectiveness Models

    Jun 1, 2024, 00:00

  • P10 Using the Health Improvement Distribution Index to Inform Equitable Machine Learning: An Example Analysis Among Patients with Type 2 Diabetes Mellitus

    Jun 1, 2024, 00:00

  • PCR265 Measurement of Health Insurance Literacy and Identification of Its Correlates Among Working-Age Cancer Survivors in the US

    Jun 1, 2024, 00:00

  • EPH199 Social Determinants of Health Associated with Delayed Medical Care in an Online Health Community

    Jun 1, 2024, 00:00
  • «
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19 (current)
  • 20
  • »